Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Post-transcriptional screen of cancer amplified genes identifies ERBB2/Her2 signaling as AU-rich mRNA stability-promoting pathway. | Oncogenesis | 2021 | 34535639 | PubTator, text mining | PubMed |
| The CRL4DTL E3 ligase induces degradation of the DNA replication initiation factor TICRR/TRESLIN specifically during S phase. | Nucleic Acids Res | 2021 | 34534348 | PubTator, text mining | PubMed |
| Nucleotide Metabolism Behind Epigenetics. | Front Endocrinol (Lausanne) | 2021 | 34526971 | PubTator, text mining | PubMed |
| Neurotoxicity of a pyrethroid pesticide deltamethrin is associated with the imbalance in proteolytic systems caused by mitophagy activation and proteasome inhibition. | Toxicol Appl Pharmacol | 2021 | 34520793 | PubTator, text mining | PubMed |
| Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC. | Thorac Cancer | 2021 | 34520129 | PubTator, text mining | PubMed |
| Biological and clinical implications of metastasis-associated circular RNAs in oesophageal squamous cell carcinoma. | FEBS Open Bio | 2021 | 34510785 | PubTator, text mining | PubMed |
| Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing. | PLoS One | 2021 | 34506539 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis. | BMC Cancer | 2021 | 34488675 | PubTator, text mining | PubMed |
| Polo-like kinase 1 (Plk1) regulates DNA replication origin firing and interacts with Rif1 in Xenopus. | Nucleic Acids Res | 2021 | 34469577 | PubTator, text mining | PubMed |
| Comprehensive analysis of pathological changes in hip joint capsule of patients with developmental dysplasia of the hip. | Bone Joint Res | 2021 | 34465146 | PubTator, text mining | PubMed |
| The Paradoxical Role of Cellular Senescence in Cancer. | Front Cell Dev Biol | 2021 | 34458273 | PubTator, text mining | PubMed |
| The SCF Complex Is Essential to Maintain Genome and Chromosome Stability. | Int J Mol Sci | 2021 | 34445249 | PubTator, text mining | PubMed |
| The Optimization and Biological Significance of a 29-Host-Immune-mRNA Panel for the Diagnosis of Acute Infections and Sepsis. | J Pers Med | 2021 | 34442377 | PubTator, text mining | PubMed |
| An Integrative Systems Biology Approach Identifies Molecular Signatures Associated with Gallbladder Cancer Pathogenesis. | J Clin Med | 2021 | 34441816 | PubTator, text mining | PubMed |
| Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors. | Life (Basel) | 2021 | 34440557 | PubTator, text mining | PubMed |
| Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay. | Future Oncol | 2021 | 34435876 | PubTator, text mining | PubMed |
| Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression. | Ann Transl Med | 2021 | 34430609 | PubTator, text mining | PubMed |
| The profiling, identification, quantification and analysis of differentially expressed genes (DEGs) in response to drug treatment in lung cancer. | MethodsX | 2021 | 34430277 | PubTator, text mining | PubMed |
| Overexpression of CXCR7 is a Novel Indicator for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Patients. | Dis Markers | 2021 | 34413914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=41